Cardiomyocyte-specific prolyl-4-hydroxylase domain 2 knock out protects from acute myocardial ischemic injury
about
HIF hydroxylase pathways in cardiovascular physiology and medicinePHD2: from hypoxia regulation to disease progressionMolecular mechanisms of ischemic preconditioning in the kidneyHuman high-altitude adaptation: forward genetics meets the HIF pathway.Remote ischaemic preconditioning: closer to the mechanism?Epidermal or dermal specific knockout of PHD-2 enhances wound healing and minimizes ischemic injury.Depletion of PHD3 protects heart from ischemia/reperfusion injury by inhibiting cardiomyocyte apoptosis.Preischemic targeting of HIF prolyl hydroxylation inhibits fibrosis associated with acute kidney injuryPHD2/3-dependent hydroxylation tunes cardiac response to β-adrenergic stress via phospholamban.Hypoxia-inducible factor prolyl hydroxylase inhibition: robust new target or another big bust for stroke therapeutics?Metabolic stress in the myocardium: adaptations of gene expression.EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection.Prolyl hydroxylase domain protein 2 silencing enhances the survival and paracrine function of transplanted adipose-derived stem cells in infarcted myocardiumActivation of hypoxia response in endothelial cells contributes to ischemic cardioprotection.Hematological, hepatic, and retinal phenotypes in mice deficient for prolyl hydroxylase domain proteins in the liverProlyl 4-hydroxylases, master regulators of the hypoxia response.Prolyl 4 hydroxylase: a critical target in the pathophysiology of diseases.Novel perspectives on the PHD-HIF oxygen sensing pathway in cardioprotection mediated by IPC and RIPCPHD2 Is a Regulator for Glycolytic Reprogramming in Macrophages.Prolyl hydroxylase domain enzymes: important regulators of cancer metabolism.The VHL Tumor Suppressor Gene: Insights into Oxygen Sensing and Cancer.Prolyl-4-hydroxylase domain 3 (PHD3) is a critical terminator for cell survival of macrophages under stress conditions.A role for prolyl hydroxylase domain proteins in hippocampal synaptic plasticity.HIF-1α and HIF-2α induce angiogenesis and improve muscle energy recovery.Unfavourable consequences of chronic cardiac HIF-1α stabilization.Pre- and post-conditional inhibition of prolyl-4-hydroxylase domain enzymes protects the heart from an ischemic insult.Hypoxia-inducible factor 2-alpha-dependent induction of amphiregulin dampens myocardial ischemia-reperfusion injury.HIF-P4H-2 deficiency protects against skeletal muscle ischemia-reperfusion injury.Ischemic preconditioning attenuates ischemia/reperfusion-induced kidney injury by activating autophagy via the SGK1 signaling pathway.
P2860
Q26862091-1DC22404-3C60-4DED-BD70-84291342F8D1Q28069316-EF34F4BC-65EF-41CF-9B13-0D3851B830AFQ28080772-9FE6E7B7-FED4-440D-A426-9238A26AD061Q34360748-B2DA1503-92AA-4A9A-95E5-6370217FDDDCQ34680698-926DF5E9-49D0-4192-BB50-E996862AAD74Q35138460-7C593B45-9106-49DF-96ED-CB20B9E91206Q35219366-E3E97FC1-15FA-4D78-8D3D-154BCA2E9325Q35994525-9535CD15-1401-41DC-A6FB-F6AFCD63C70CQ36040250-EDE8E3E8-D8F8-4750-99AA-1114ABF8C17BQ36079321-C10CBD07-1099-4A43-A46B-30BE4EAF1837Q36328486-86D2CDC1-E813-4AB6-87B5-7E56162EE016Q36762987-C46A21F4-1C2E-4F5D-B764-F31426BF1C8DQ37097008-4935C112-96BA-498E-AD0F-7DF7B7D7D5CFQ37122871-0F8948EB-4646-487E-852C-9A01B68E3C8BQ37672906-BB5C4A87-20D2-4E5D-B510-543BE5232DF5Q38089239-4D9A5484-1B06-4192-9D59-E39714FCF977Q38102681-5D1D45A3-51E0-43E6-A05B-2F33946E6B3BQ38515317-FB8D917E-8960-46C2-B094-7DE24BF0DFBFQ38735114-0555906F-4DD9-454A-8FB3-686A58F3468EQ38989140-CDFD4832-35BF-4632-A819-A6B2CAB1D86FQ41112435-08D53CCA-28A6-47D5-A540-AF8E09663829Q42291109-D46734B4-35E8-44AD-A84B-0729872932E1Q45753972-7D5E9A33-3A65-4976-9630-AA46D5FC1BE8Q45868472-5A7F2D56-2823-468B-8BA9-1DC5A7524850Q46246985-F78600D6-354D-4A53-A1F8-C7EF60504672Q48750289-D6519535-6AD6-4BE4-87FF-F6323D6E9131Q52684329-57DCF430-DA04-4EA9-B6BA-676E05F5167AQ53317012-5F104D24-9AAF-4D0A-A19D-F0BE5DCCA767Q55017710-306A61B4-83F6-4713-95C7-37EABFFB82C5
P2860
Cardiomyocyte-specific prolyl-4-hydroxylase domain 2 knock out protects from acute myocardial ischemic injury
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Cardiomyocyte-specific prolyl- ...... ute myocardial ischemic injury
@ast
Cardiomyocyte-specific prolyl- ...... ute myocardial ischemic injury
@en
Cardiomyocyte-specific prolyl- ...... ute myocardial ischemic injury
@nl
type
label
Cardiomyocyte-specific prolyl- ...... ute myocardial ischemic injury
@ast
Cardiomyocyte-specific prolyl- ...... ute myocardial ischemic injury
@en
Cardiomyocyte-specific prolyl- ...... ute myocardial ischemic injury
@nl
prefLabel
Cardiomyocyte-specific prolyl- ...... ute myocardial ischemic injury
@ast
Cardiomyocyte-specific prolyl- ...... ute myocardial ischemic injury
@en
Cardiomyocyte-specific prolyl- ...... ute myocardial ischemic injury
@nl
P2093
P2860
P356
P1476
Cardiomyocyte-specific prolyl- ...... ute myocardial ischemic injury
@en
P2093
Amke Hesse
Anke Zieseniss
Dörthe M Katschinski
Marion Hölscher
Melanie von Ahlen
Monique Silter
Peter Schwartz
Sabine Krull
P2860
P304
11185-11194
P356
10.1074/JBC.M110.186809
P407
P577
2011-01-26T00:00:00Z